Chiedi
Consulta
Scopri
Calcola
Registrati
Registrati
Accedi
Accedi
Scopri
NPM1-mutated relapsed/refractory AML: ziftomenib gains FDA approval as an oral menin inhibitor option - Notizie Vera Health